Absolicon Solar Collector AB är ett svenskt bolag som utvecklar, tillverkar och säljer robotiserade ...
Magnitude of soft year-end misunderstood In mid-December, Fiskars communicated an expected FY'22 adj...
Relais’ CFO Pekka Raatikainen is stepping down by the end of June to pursue career outside the compa...
Redeye states that the announced extension agreement in Operating Systems indicates a slower decline...
IRLAB Therapeutics has announced that it has selected a drug candidate from its P003 discovery progr...
Förvärvet av UBConnect exemplifierar strategin… Transtema planerar att växa i tre dimensioner – i nä...
Redeye comments on AVTECH's preliminary numbers for Q4'22 which was largely in line with our estimat...
OrderYOYO announced on Thursday, January 12th, the company’s performance during Q4-22.
Redeye states that Neonode’s patent 879 is judged not to be unpatentable – implying a crucial win fo...
Redeye is encouraged by Adverty's momentum in increasing its reach on the supply side and the increa...
Redeye comments on the news released earlier today, Wyld Networks has received a large order for its...
Redeye endorses yesterday’s news that Alzecure has chosen a candidate drug for its second project wi...
Investors House announced yesterday (11 January) that its zoning plan for Neilikkatie 17 in Tikkuril...
Redeye provides a research update following the Q1 report published by Newbury yesterday.
Q4 results due Friday, 10 February Sales +32% y-o-y on recent order momentum We cut '23e-'24e EBIT b...
Previous pre-tax profit guidance interval of DKK 500m-600m.
Redeye slightly adjusts our expectations on 2023e based on the price adjustments made by CMS in the ...
Redeye leaves an initial comment following the Q1 report published by Newbury this morning.
Q4 report due on Tuesday, 7 February We expect EBIT margin to bottom out at 9.
We raise our adjusted EBIT estimates by 6% for 2023-24, mainly as a consequence of the implementatio...
